The Current Ratio as of December 2025 (TTM) for Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) is 12.65

According to Shanghai Bio-heart Biological Technology Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 12.65. This represents a change of -30.56% compared to the average of 18.21 of the last 4 quarters.

Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) Historical Current Ratio (quarterly & annually)

How has 2185.HK Current Ratio performed in the past?

The mean historical Current Ratio of Shanghai Bio-heart Biological Technology Co., Ltd. over the last ten years is 17.54. The current 12.65 Current Ratio has changed 7.11% with respect to the historical average. Over the past ten years (40 quarters), 2185.HK's Current Ratio was at its highest in in the June 2024 quarter at 24.62. The Current Ratio was at its lowest in in the June 2021 quarter at 0.

Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Shanghai Bio-heart Biological Technology Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) Average Current Ratio

How has 2185.HK Current Ratio performed in the past?

The current Current Ratio of Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) Current Ratio vs. Peers

How is 2185.HK’s Current Ratio compared to its peers?

Shanghai Bio-heart Biological Technology Co., Ltd.’s Current Ratio is greater than SinoMab BioScience Limited (0.87), greater than HighTide Therapeutics Inc (3.44), greater than Mabpharm Limited (1.07), greater than Immunotech Biopharm Ltd (0.08), greater than Zhaoke Ophthalmology Limited (4.40), greater than Cutia Therapeutics (3.16), greater than JW (Cayman) Therapeutics Co. Ltd (1.59), greater than C-MER Medical Holdings Limited (1.51), greater than 3D Medicines Inc. (1.59), greater than Frontage Holdings Corporation (1.24),

Build a custom stock screener for Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Bio-heart Biological Technology Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shanghai Bio-heart Biological Technology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.